Which medication is associated with myopia and secondary angle-closure glaucoma?

Study for the NBEO Part II TMOD Exam. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam!

Multiple Choice

Which medication is associated with myopia and secondary angle-closure glaucoma?

Explanation:
Topiramate can cause acute myopia with secondary angle-closure glaucoma through ciliochoroidal effusion that pushes the iris-lens diaphragm forward. This forward shift shallows the anterior chamber and narrows the angle, leading to a rapid rise in intraocular pressure. It often occurs within days to weeks after starting the medication and can be bilateral. This mechanism is different from pupillary-block glaucoma, so pilocarpine may not help and can worsen the situation; the key treatment is stopping topiramate and lowering IOP with appropriate medications, plus strategies to move the iris-lens diaphragm back (such as cycloplegics) and sometimes a short course of steroids to reduce edema. The other listed drugs aren’t typically associated with this characteristic pattern of myopia plus angle-closure glaucoma.

Topiramate can cause acute myopia with secondary angle-closure glaucoma through ciliochoroidal effusion that pushes the iris-lens diaphragm forward. This forward shift shallows the anterior chamber and narrows the angle, leading to a rapid rise in intraocular pressure. It often occurs within days to weeks after starting the medication and can be bilateral. This mechanism is different from pupillary-block glaucoma, so pilocarpine may not help and can worsen the situation; the key treatment is stopping topiramate and lowering IOP with appropriate medications, plus strategies to move the iris-lens diaphragm back (such as cycloplegics) and sometimes a short course of steroids to reduce edema. The other listed drugs aren’t typically associated with this characteristic pattern of myopia plus angle-closure glaucoma.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy